Rakesh Dahiya
Wednesday, April 13, 2022
DCGI approves Glenmark’s phase-I clinical trial for its novel molecule GRC 54276
https://thehealthmaster.com/?p=36686
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment